Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Pittman

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Thrombosis and Haemostasis : JTH|June 17, 2018
A first-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of PF-06741086, an anti-tissue factor pathway inhibitor mAb, in healthy volunteersM Cardinal, C Kantaridis, T Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activityJ J Toole, D D Pittman, E C Orr, et al.
The Journal of Biological Chemistry|November 5, 1988
The binding of 35S-labeled recombinant factor VIII to activated and unactivated human plateletsM E Nesheim, D D Pittman, J H Wang, et al.
Blood|June 1, 1993
Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIIID D Pittman, E M Alderman, K N Tomkinson, et al.
The Journal of Biological Chemistry|September 25, 1991
The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human plateletsM Nesheim, D D Pittman, A R Giles, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 28, 2015
Using a Systems Pharmacology Model of the Blood Coagulation Network to Predict the Effects of Various Therapies on BiomarkersS Nayak, D Lee, S Patel-Hett, et al.
The Journal of Gene Medicine|July 5, 2001
Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapyG Turgeman, D D Pittman, R Müller, et al.
Gene Therapy|August 27, 2003
Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the ratJ Z Li, H Li, T Sasaki, et al.
Journal of Neurosurgery|July 21, 1999
Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapyT D Alden, D D Pittman, E J Beres, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Complete cDNA and derived amino acid sequence of human factor VR J Jenny, D D Pittman, J J Toole, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Thrombosis and Haemostasis : JTH|June 17, 2018
A first-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of PF-06741086, an anti-tissue factor pathway inhibitor mAb, in healthy volunteersM Cardinal, C Kantaridis, T Zhu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1986
A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activityJ J Toole, D D Pittman, E C Orr, et al.
The Journal of Biological Chemistry|November 5, 1988
The binding of 35S-labeled recombinant factor VIII to activated and unactivated human plateletsM E Nesheim, D D Pittman, J H Wang, et al.
Blood|June 1, 1993
Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIIID D Pittman, E M Alderman, K N Tomkinson, et al.
The Journal of Biological Chemistry|September 25, 1991
The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human plateletsM Nesheim, D D Pittman, A R Giles, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 28, 2015
Using a Systems Pharmacology Model of the Blood Coagulation Network to Predict the Effects of Various Therapies on BiomarkersS Nayak, D Lee, S Patel-Hett, et al.
The Journal of Gene Medicine|July 5, 2001
Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapyG Turgeman, D D Pittman, R Müller, et al.
Gene Therapy|August 27, 2003
Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the ratJ Z Li, H Li, T Sasaki, et al.
Journal of Neurosurgery|July 21, 1999
Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapyT D Alden, D D Pittman, E J Beres, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1987
Complete cDNA and derived amino acid sequence of human factor VR J Jenny, D D Pittman, J J Toole, et al.
Pageof 4